CoChat

SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer

Open access
Santolla, M F, Avino, S, Pellegrino, M, De Francesco, E M, De Marco, P, Lappano, R, Vivacqua, A, Cirillo, F, Rigiracciolo, D C, Scarpelli, A, Abonante, S, Maggiolini, M · 2015 · Cell Death & Disease
Cited by 90

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

A number of tumors exhibit an altered expression of sirtuins, including NAD+-dependent histone deacetylase silent information regulator 1 (SIRT1) that may act as a tumor suppressor or tumor promoter mainly depending on the tumor types. For instance, in breast cancer cells SIRT1 was shown to exert an essential role toward the oncogenic signaling mediated by the estrogen receptor-α (ER α). In accordance with these findings, the suppression of SIRT1 led to the inhibition of the transduction pathway triggered by ER α. As the regulation of SIRT1 has not been investigated in cancer cells lacking ER, in the present study we ascertained the expression and function of SIRT1 by estrogens in ER-negative breast cancer cells and cancer-associated fibroblasts obtained from breast cancer patients. Our results show that 17 β-estradiol (E2) and the selective ligand of GPER, namely G-1, induce the expression of SIRT1 through GPER and the subsequent activation of the EGFR/ERK/c-fos/AP-1 transduction pathway. Moreover, we demonstrate that SIRT1 is involved in the pro-survival effects elicited by E2 through GPER, like the prevention of cell cycle arrest and cell death induced by the DNA damaging agent etoposide. Interestingly, the aforementioned actions of estrogens were abolished silencing GPER or SIRT1, as well as using the SIRT1 inhibitor Sirtinol. In addition, we provide evidence regarding the involvement of SIRT1 in tumor growth stimulated by GPER ligands in breast cancer cells and xenograft models. Altogether, our data suggest that SIRT1 may be included in the transduction network activated by estrogens through GPER toward the breast cancer progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cddis.2015.201

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 90

Metadata

Authors
Santolla, M. F., Avino, S., Pellegrino, M., De Francesco, E. M., De Marco, P., Lappano, R., Vivacqua, A., Cirillo, F., Rigiracciolo, D. C., Scarpelli, A., Abonante, S., & Maggiolini, M.
Venue
Cell Death & Disease
Published
2015-07-30
Volume
6
Issue
7
Pages
e1834-e1834
ISSN
2041-4889 (ISSN-L)
OpenAlex
W966259483
Cited by
90
References
10
FWCI
7.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. https://app.cochat.ai/papers/10.1038/cddis.2015.201
The paper
Santolla, M. F., Avino, S., Pellegrino, M., De Francesco, E. M., De Marco, P., Lappano, R., Vivacqua, A., Cirillo, F., Rigiracciolo, D. C., Scarpelli, A., Abonante, S., & Maggiolini, M. (2015). SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Cell Death & Disease. https://doi.org/10.1038/cddis.2015.201

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.